Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer (Nature Communications, (2019), 10, 1, (4682), 10.1038/s41467-019-12657-w)

Katherine A. Michaelis, Mason A. Norgard, Xinxia Zhu, Peter R. Levasseur, Shamilene Sivagnanam, Shannon M. Liudahl, Kevin G. Burfeind, Brennan Olson, Katherine R. Pelz, Diana M.Angeles Ramos, H. Carlo Maurer, Kenneth P. Olive, Lisa M. Coussens, Terry K. Morgan, Daniel L. Marks

Research output: Contribution to journal › Comment/debate › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer (Nature Communications, (2019), 10, 1, (4682), 10.1038/s41467-019-12657-w)'. Together they form a unique fingerprint.

Physics & Astronomy

Medicine & Life Sciences

Chemical Compounds